Skip to main content

FDA recall, , Moderate risk

Philips Azurion System

Issue 1 - System remains in continuous restart mode after the start-up.

What happened

Philips Medical Systems Nederland B.V., located in Best, Netherlands, recalled its Philips Azurion system with Software Version Number R3.1. The company identified two software issues that may result in loss of imaging (X-ray) functionality and/or loss of motorized movement, and/or incorrect image content and/or loss of data.

The first issue involves the system remaining in continuous restart mode after start-up, while the second issue, a longitudinal position error, applies only to systems with a Poly-G3 frontal stand.

The recall, which began on December 12, 2025, affects 228 units distributed internationally, including in countries such as AE, AR, AT, AZ, BE, BG, BH, BR, BS, CH, CL, CO, CR, CY, CZ, DE, DK, DZ, EC, EG, ES, GB, GR, GT, ID, IE, IL, IN, IQ, IT, JE, JP, LB, MA, MO, NI, NL, NO, PE, PL, RO, SA, SE, SV, TR, UA, VE, VN, and ZA, as well as in U.S. states including Arkansas, Arizona, Colorado, Delaware, Idaho, Illinois, Indiana, Massachusetts, and Missouri.

The FDA added the recall to its Enforcement Report on January 16, 2026.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its UDI-DI is listed.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Philips Azurion system; Software Version Number: R3.1;

    UDI-DI
    • 00884838099203
    • 00884838099210
    • 00884838099241
    • 00884838099258
    • 00884838099265
    • 00884838099272
    • 00884838099227
    • 00884838099234
    • 00884838116726
    • 00884838116733
    • 00884838116740
    • 00884838116757
    • 00884838116764
    • 00884838116771
    • 00884838116788
    • 00884838116801

Recall details

Company began the recall
Sold in

International distribution in the countries of AE, Arkansas, AT, Arizona, BE, BG, BH, BR, BS, CH, CL, Colorado, CR, CY, CZ, Delaware, DK, DZ, EC, EG, ES, GB, GR, GT, Idaho, IE, Illinois, Indiana, IQ, IT, JE, JP, LB, Massachusetts, Missouri, NI, NL, NO, PE, PL, RO, SA, SE, SV, TR, UA, VE, VN, ZA;

Company
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.Best, Netherlands
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98108
Recall number
Z-1113-2026
Quantity recalled
228 units (all OUS)

All recalls from PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 23, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)